SeaStar Medical Holding Corporation
General ticker "ICU" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $114.0M (TTM average)
SeaStar Medical Holding Corporation follows the US Stock Market performance with the rate: 6.0%.
Estimated limits based on current volatility of 7.4%: low 3.66$, high 4.24$
Factors to consider:
- Total employees count: 17 (-10.5%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Significant losses, Operational and conduct risks, Going concern doubt, FDA approval delays, Single business dependence
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.36$, 23.54$]
- 2025-12-31 to 2026-12-31 estimated range: [2.98$, 12.89$]
Financial Metrics affecting the ICU estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -46.87 <= 7.04
- Negative: Investing cash flow per share per price, % of 0 <= 2.08
- Negative: negative Industry operating income (median)
- Negative: 2.54 < Interest expense per share per price, % of 3.22
- Negative: negative Industry operating cash flow (median)
Short-term ICU quotes
Long-term ICU plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.14MM |
| Operating Expenses | $11.61MM | $14.21MM | $17.98MM |
| Operating Income | $-11.61MM | $-14.21MM | $-17.84MM |
| Non-Operating Income | $-0.58MM | $-12.02MM | $-6.99MM |
| Interest Expense | $0.63MM | $1.08MM | $0.24MM |
| R&D Expense | $2.50MM | $5.97MM | $9.11MM |
| Income(Loss) | $-12.19MM | $-26.23MM | $-24.83MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-12.19MM | $-26.23MM | $-24.83MM |
| Stockholders Equity | $-20.76MM | $-13.87MM | $-2.18MM |
| Assets | $3.04MM | $3.51MM | $4.66MM |
| Operating Cash Flow | $-7.79MM | $-10.29MM | $-16.01MM |
| Financing Cash Flow | $7.33MM | $10.41MM | $17.65MM |
| Earnings Per Share** | $-233.83 | $-302.63 | $-66.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.